Pharmaceuticals

FDA approves Farxiga to improve blood sugar control in pediatric patients with type 2 diabetes

bexib
By bexib 0 Min Read

In addition to being approved for the treatment of heart failure, AstraZeneca’s Farciga is approved by the FDA as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes.

You Might Also Like

AI Pulse Check

Embracing FSP: Q&A with Jenny Denny

Pricing environment influencing commercial considerations

Legal environment regarding in vitro fertilization and other assisted reproductive technologies following decisions of the Alabama Supreme Court and the Legislature

AbbVie and Gilgamesh Pharmaceuticals agree to terms of collaboration to develop advanced treatments for mental illnesses

Share This Article
Previous Article Biden campaign reportedly considering Bitcoin, cryptocurrency donations
Next Article Strawberry Nursery Establishment and Management
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Solent Hotel has completed a 6 -digit spa and wellness renovation
Hospitality & Tourism
Five payment trends in Asia that will shape the financial landscape in 2025
Fintech
BNPL drives growth for suppliers and retailers
Retail & E-commerce
Hotel chef obtains new qualification
Hospitality & Tourism